Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Crystal L Mackall

Showing results (161-170 of 232) with videos related to

Pageof 24
Sort By:
Molecular Therapy. Methods & Clinical Development|September 14, 2018
Screening Clinical Cell Products for Replication Competent Retrovirus: The National Gene Vector Biorepository ExperienceKenneth Cornetta, Lisa Duffy, Steven A Feldman, et al.
Lancet (London, England)|October 17, 2014
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trialDaniel W Lee, James N Kochenderfer, Maryalice Stetler-Stevenson, et al.
Annals of the New York Academy of Sciences|November 13, 2020
Frontiers in cancer immunotherapy-a symposium reportJennifer Cable, Benjamin Greenbaum, Dana Pe'er, et al.
Nature Communications|October 6, 2024
GLUT1 overexpression in CAR-T cells induces metabolic reprogramming and enhances potencyJustin A Guerrero, Dorota D Klysz, Yiyun Chen, et al.
Nature|March 8, 2023
Co-opting signalling molecules enables logic-gated control of CAR T cellsAidan M Tousley, Maria Caterina Rotiroti, Louai Labanieh, et al.
Cancer Cell|June 24, 2022
Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistenceJulia A Belk, Winnie Yao, Nghi Ly, et al.
Nature Methods|July 15, 2020
Novel NanoLuc substrates enable bright two-population bioluminescence imaging in animalsYichi Su, Joel R Walker, Yunhee Park, et al.
Blood Cancer Discovery|December 18, 2025
Clinical and Cytokine Features of Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like SyndromeHrishikesh K Srinagesh, Anne Marijn Kramer, John H Baird, et al.
Nature Medicine|January 9, 2024
Unanswered questions following reports of secondary malignancies after CAR-T cell therapyBruce L Levine, Marcelo C Pasquini, John E Connolly, et al.
Lancet (London, England)|July 12, 2024
CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 studyMatthew J Frank, John H Baird, Anne Marijn Kramer, et al.
Pageof 24

Showing results (161-170 of 232) with videos related to

Sort By:
Pageof 24
Molecular Therapy. Methods & Clinical Development|September 14, 2018
Screening Clinical Cell Products for Replication Competent Retrovirus: The National Gene Vector Biorepository ExperienceKenneth Cornetta, Lisa Duffy, Steven A Feldman, et al.
Lancet (London, England)|October 17, 2014
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trialDaniel W Lee, James N Kochenderfer, Maryalice Stetler-Stevenson, et al.
Annals of the New York Academy of Sciences|November 13, 2020
Frontiers in cancer immunotherapy-a symposium reportJennifer Cable, Benjamin Greenbaum, Dana Pe'er, et al.
Nature Communications|October 6, 2024
GLUT1 overexpression in CAR-T cells induces metabolic reprogramming and enhances potencyJustin A Guerrero, Dorota D Klysz, Yiyun Chen, et al.
Nature|March 8, 2023
Co-opting signalling molecules enables logic-gated control of CAR T cellsAidan M Tousley, Maria Caterina Rotiroti, Louai Labanieh, et al.
Cancer Cell|June 24, 2022
Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistenceJulia A Belk, Winnie Yao, Nghi Ly, et al.
Nature Methods|July 15, 2020
Novel NanoLuc substrates enable bright two-population bioluminescence imaging in animalsYichi Su, Joel R Walker, Yunhee Park, et al.
Blood Cancer Discovery|December 18, 2025
Clinical and Cytokine Features of Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like SyndromeHrishikesh K Srinagesh, Anne Marijn Kramer, John H Baird, et al.
Nature Medicine|January 9, 2024
Unanswered questions following reports of secondary malignancies after CAR-T cell therapyBruce L Levine, Marcelo C Pasquini, John E Connolly, et al.
Lancet (London, England)|July 12, 2024
CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 studyMatthew J Frank, John H Baird, Anne Marijn Kramer, et al.
Pageof 24